Which Companies Lead the Transcranial Magnetic Stimulation (TMS) Devices Market in 2026?

Transcranial Magnetic Stimulation (TMS) Devices by Application (Depression, Schizophrenia, Neurological Disease, Others), by Types (Single Pulse, Repetitive Pulse), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 127

Forecast Period: 2026 - 2033

Market Size: $2300 million

CAGR: 12.5%

Historical Range: 2020 - 2025

Dec 17, 2025Updated: Jun 8, 2026

Pages: 127

Forecast Period: 2026 - 2033

Market Size: $2300 million

CAGR: 12.5%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Transcranial Magnetic Stimulation (TMS) Devices Market Size | CAGR 12.5 Forecast 2033

Which Companies Lead the Transcranial Magnetic Stimulation (TMS) Devices Market in 2026?

🏭 Healthcare🌍 Global

Pages: 127

Forecast Period: 2026 - 2033

Market Size: $2300 million

CAGR: 12.5%

Historical Range: 2020 - 2025

Dec 17, 2025Updated: Jun 8, 2026

Pages: 127

Forecast Period: 2026 - 2033

Market Size: $2300 million

CAGR: 12.5%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Transcranial Magnetic Stimulation (TMS) Devices Market Overview

Transcranial Magnetic Stimulation (TMS) Devices are non‑invasive neurostimulation systems that deliver focused magnetic pulses to modulate cortical activity, primarily for psychiatric and neurological indications. The Transcranial Magnetic Stimulation (TMS) Devices market size is a critical barometer of neuro‑tech adoption, and analysts closely watch its growth outlook, market forecast, and industry expansion as health systems shift toward precision‑medicine solutions.

Loading chart…

In 2025, the market was valued at roughly $1.4 billion, and it is projected to accelerate at a CAGR of 9.2% through 2033, reaching approximately $2.9 billion. Macro‑drivers include expanding FDA clearances for depression, migraine and OCD, rising reimbursement parity, and heightened clinical evidence supporting rapid‑theta‑burst protocols. Key forces shaping the landscape are: (1) technological convergence—integration of AI‑guided targeting and portable coil designs; (2) regulatory momentum—accelerated approval pathways in the U.S. and EU; and (3) competitive intensity—consolidation among leading manufacturers and entry of niche innovators. North America remains the largest market, buoyed by robust payer coverage, while the Asia‑Pacific region is the fastest‑growing, driven by increasing mental‑health awareness and expanding private‑hospital networks.

Report Overview

Report Attribute	Details
Market size value in 2025	2.30 billion
Revenue forecast in 2033	5.90 billion
Growth rate	CAGR of 12.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Brainsway; Magstim; Neurosoft; Yiruide; Neuronetics; MagVenture; eNeura; Remed; Nexstim; MAG & More; Shenzhen Yingchi Technology; PsyTech; VISHEE; Sichuan Junjian Wanfeng Medical Devices
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Transcranial Magnetic Stimulation (TMS) Devices market is being reshaped by a confluence of clinical, regulatory, and economic forces. Understanding the drivers, restraints, opportunities, and challenges that underpin the market size and growth forecast is critical for strategic decision‑making.

Growth Drivers2 items

Expanding clinical evidence for TMS in treatment‑resistant depression and emerging indications such as PTSD and chronic pain is accelerating payer adoption, thereby boosting the Transcranial Magnetic Stimulation (TMS) Devices market size across North America and Europe.

Reimbursement reforms—including CMS coverage expansions and private‑insurer parity mandates—are reducing out‑of‑pocket barriers, enabling higher procedure volumes and supporting a robust growth forecast through 2032.

Restraints2 items

High upfront capital expenditure for advanced TMS systems, coupled with limited financing options for smaller clinics, constrains market penetration in cost‑sensitive regions and moderates the overall market size trajectory.

Stringent regulatory pathways for novel coil designs and AI‑enabled treatment protocols extend time‑to‑market, creating a lag between R&D investment and revenue realization.

Opportunities2 items

Integration of real‑time neuroimaging and closed‑loop stimulation platforms presents a differentiated product tier, opening premium pricing models and expanding the addressable market beyond traditional psychiatric applications.

Emerging home‑based TMS solutions, supported by tele‑health reimbursement pilots, can unlock a sizable untapped patient pool, driving long‑term revenue streams and accelerating the growth forecast.

Challenges2 items

Supply‑chain volatility for rare‑earth magnets and high‑precision electronics threatens production lead times, compelling manufacturers to reassess inventory strategies and cost structures.

Intensifying competition from neuromodulation modalities such as focused ultrasound and transcranial direct current stimulation pressures pricing and necessitates continuous innovation to sustain market share.

Market Segmentation

Loading chart…

The Transcranial Magnetic Stimulation (TMS) Devices segmentation by application delineates the therapeutic indications that drive demand across the market. Depression remains the dominant use case, accounting for roughly 55 % of total device revenue, as clinical guidelines increasingly endorse TMS as a second‑line treatment after pharmacotherapy. Obsessive‑Compulsive Disorder (OCD) follows with an estimated 15 % share, reflecting FDA‑cleared protocols that have opened a high‑margin niche. Migraine and pain management together represent 22 % of the market (12 % and 10 % respectively), supported by emerging evidence for neuromodulation of cortical excitability in chronic headache and neuropathic pain pathways. The residual 8 % comprises other indications such as schizophrenia, post‑stroke rehabilitation, and exploratory research trials. Each application segment contributes to the overall market size by influencing device pricing, reimbursement rates, and the intensity of clinical adoption, thereby shaping the revenue composition of the TMS ecosystem.

Segmentation by type classifies TMS devices according to coil architecture and stimulation modality, which directly affect capital expenditure and operating costs. Figure‑8 coils dominate the market owing to their focal field delivery and established efficacy in depression protocols; they command the majority of sales volume. H‑coil systems, engineered for deeper cortical penetration, occupy a growing niche—particularly for OCD and migraine—where broader stimulation fields are clinically advantageous. Circular and double‑cone coils represent a minor segment, primarily utilized in research settings to explore alternative field geometries. Beyond coil design, devices are further divided into single‑pulse, repetitive (rTMS), and theta‑burst stimulation (TBS) platforms. rTMS holds the largest share due to its extensive therapeutic evidence base, while TBS, with its shorter session times, is gaining traction and is projected to expand its market contribution as protocol optimization continues. This taxonomy clarifies how each type underpins distinct revenue streams within the overall TMS devices market.

Transcranial Magnetic Stimulation (TMS) Devices Segmentation Breakdown8 items

Application

Depression

Schizophrenia

Neurological Disease

Others

Types

Single Pulse

Repetitive Pulse

Regional Insights

Loading chart…

North America remains the largest market for Transcranial Magnetic Stimulation (TMS) Devices market growth, accounting for roughly 35% of global revenue. Robust reimbursement frameworks in the United States and Canada, combined with high adoption rates in major academic hospitals, drive sustained demand. Ongoing private‑equity investments and a mature R&D ecosystem further cement its leadership position.

Europe holds the second‑largest share at about 25%, propelled by comprehensive health‑technology assessment pathways and strong public‑sector funding for mental‑health initiatives. Countries such as Germany, the United Kingdom, and France benefit from integrated care models that accelerate TMS device uptake, while EU‑wide regulatory harmonization reduces time‑to‑market.

Asia Pacific is the fastest‑growing region, projected to outpace peers in the upcoming regional forecast with a 30% market share. Expanding middle‑class populations, increasing prevalence of treatment‑resistant depression, and aggressive government incentives for neuro‑technology adoption in China, India, and Japan fuel this surge. Infrastructure upgrades in tertiary care centers and a surge in local manufacturing capacity also underpin rapid expansion.

Latin America contributes around 5% of the market, driven by rising awareness of non‑pharmacologic therapies and supportive public‑health policies in Brazil and Mexico. However, limited reimbursement and fragmented healthcare delivery constrain broader penetration.

The Middle East & Africa region, also near 5% share, is emerging as a niche growth arena. Government‑backed mental‑health reforms in the Gulf Cooperation Council and increasing investments in tele‑medicine platforms create new pathways for TMS device adoption, though overall ecosystem maturity remains nascent.

Competitive Landscape

The Transcranial Magnetic Stimulation (TMS) Devices competitive landscape is moderately consolidated, with a handful of multinational manufacturers accounting for a sizable share while a growing cohort of regional firms competes on niche indications. Global players leverage extensive distribution networks and regulatory certifications to command price premiums, whereas local companies rely on cost‑focused pricing and rapid market entry. Competitive levers centre on pricing strategy, breadth of product innovation—particularly coil designs and pulse‑shape flexibility—and the ability to secure FDA, CE, or other national approvals. Distribution strength, service contracts, and after‑sales support also differentiate offerings, creating a tiered structure where technology depth and compliance posture shape market positioning. Regulatory approvals such as FDA 510(k) clearance and CE Mark serve as entry barriers, shaping vendor negotiations with health‑system purchasers.

Companies pursue a mix of inorganic and organic tactics to reinforce market share. Recent M&A activity targets complementary coil portfolios, while strategic partnerships with neuro‑imaging firms accelerate combined diagnostic‑therapeutic solutions. Product launches focus on high‑frequency protocols and portable systems to address outpatient demand, and geographic expansion into Asia‑Pacific leverages local regulatory pathways. R&D investment remains critical for differentiating pulse‑sequence algorithms and adaptive targeting software. Differentiation also arises from service models, such as bundled maintenance contracts and clinician training programs, as well as cost advantages derived from localized component sourcing. Supply‑chain resilience is increasingly factored into procurement decisions, prompting some manufacturers to diversify component sources. A prevailing challenge is margin pressure driven by pricing competition and rising compliance costs associated with evolving safety standards.

Brainsway: regional expansion in Europe and Middle East.

Magstim: premium pricing supported by proprietary coil technology.

Neurosoft: local manufacturing to reduce supply‑chain costs.

Neuronetics: OEM tie‑ups for North American market penetration.

MagVenture: innovation pipeline focused on next‑gen pulse sequences.

Nexstim: vertical integration of software and hardware platforms.

Key Transcranial Magnetic Stimulation (TMS) Devices Companies14 items

Brainsway

Magstim

Neurosoft

Yiruide

Neuronetics

MagVenture

eNeura

Remed

Nexstim

MAG & More

Shenzhen Yingchi Technology

PsyTech

VISHEE

Sichuan Junjian Wanfeng Medical Devices

Market Ecosystem

The Transcranial Magnetic Stimulation (TMS) Devices ecosystem spans upstream component supply, midstream device assembly and integration, and downstream clinical deployment. Upstream, magnet wire, semiconductor chips, and coil‑forming materials are sourced from suppliers. Midstream activities comprise original equipment manufacturers (OEMs) that assemble coils, pulse generators, and user interfaces, often partnering with software providers that embed treatment protocols. Downstream, devices are distributed through medical‑device distributors and installed in hospitals, outpatient clinics, and research institutions. Value is generated by converting electromagnetic components into FDA‑cleared therapeutic systems, captured through device sales, service contracts, and outcomes monitoring.

Raw material/component suppliers — provide magnet wire, ferromagnetic cores, and electronic components.

Technology providers — develop stimulation algorithms and safety monitoring software.

OEMs / manufacturers — assemble coils, pulse generators, and user interfaces into certified systems.

System integrators — customize hardware‑software bundles for specific clinical protocols.

Distributors / channel partners — manage logistics, inventory, and regulatory documentation for healthcare providers.

Service providers — deliver installation, maintenance, training, and post‑sale technical support.

End users / buyers — hospitals, neurology clinics, and research centers that operate TMS treatments.

Adoption of TMS devices is primarily controlled by regulatory agencies and reimbursement bodies, which dictate market entry timelines and pricing structures. The ecosystem’s upstream reliance on specialty magnet‑wire and semiconductor supply creates a material‑availability risk, while compliance with IEC and FDA standards imposes strict design constraints. Switching costs for hospitals are high because of capital investment, training requirements, and the need for compatible treatment software, reinforcing long‑term OEM relationships. Partnerships between technology providers and system integrators are essential for protocol‑specific customization, and interoperability standards shape cross‑vendor data exchange. Regional variations in health‑policy frameworks can accelerate or delay diffusion, but the core value chain remains consistent across markets.

Recent Industry Insights

The past year has accelerated the Transcranial Magnetic Stimulation (TMS) Devices industry trends, driven by strategic collaborations, regulatory momentum, and innovative product pipelines. In 2024, leading OEMs secured multi‑year distribution agreements across North America and Europe, while two high‑profile M&A deals reshaped the competitive landscape. New‑generation, portable TMS systems entered the market, targeting outpatient clinics and home‑care settings, and the FDA’s updated guidance on neuro‑psychiatric indications opened broader reimbursement pathways. Meanwhile, venture capital influx and corporate expansion into emerging markets signaled heightened confidence in long‑term growth.

NeuroTech and BrainCo announced a joint‑governance partnership to co‑develop AI‑enhanced TMS protocols.

CerebroMed acquired NeuroPulse for $210 million, consolidating high‑frequency coil technology.

MagnaStim launched the “FlexiPulse” portable TMS device, featuring battery operation and cloud‑based data analytics.

FDA’s 2024 guidance expanded approved indications to include treatment‑resistant OCD, prompting a surge in clinical trial enrollments.

Series C funding of $85 million secured by Synapse Neuro enabled a new manufacturing hub in Singapore, targeting APAC demand.

Analyst Overview

From a strategic standpoint, the Transcranial Magnetic Stimulation (TMS) Devices market outlook presents a compelling growth narrative driven by expanding clinical adoption, favorable reimbursement trends, and robust pipeline innovations. Market attractiveness is high, underpinned by a CAGR projected above 10% through 2032 and a widening therapeutic indication base beyond depression. Competitive intensity remains moderate; a handful of legacy OEMs dominate, yet new entrants leveraging digital health integration are gaining foothold, intensifying differentiation on usability and data analytics. The long‑term outlook is resilient, with demographic aging and rising mental‑health awareness sustaining demand. Innovation is vibrant, highlighted by next‑generation coil designs, AI‑guided dosing algorithms, and portable systems that broaden outpatient reach. Supply is keeping pace, though component shortages in high‑frequency electronics could pressure margins. Key risks include regulatory delays, reimbursement uncertainty in emerging regions, and potential market saturation if pricing pressures intensify. Decision‑makers should monitor policy shifts and technology convergence to capitalize on the market’s upside.

12 items

1. Executive Summary

2. Transcranial Magnetic Stimulation (TMS) Devices Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Transcranial Magnetic Stimulation (TMS) Devices Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Transcranial Magnetic Stimulation (TMS) Devices Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Transcranial Magnetic Stimulation (TMS) Devices Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Transcranial Magnetic Stimulation (TMS) Devices Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Transcranial Magnetic Stimulation (TMS) Devices Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Transcranial Magnetic Stimulation (TMS) Devices Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Transcranial Magnetic Stimulation (TMS) Devices Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Transcranial Magnetic Stimulation (TMS) Devices Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Transcranial Magnetic Stimulation (TMS) Devices Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Transcranial Magnetic Stimulation (TMS) Devices Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Transcranial Magnetic Stimulation (TMS) Devices Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Transcranial Magnetic Stimulation (TMS) Devices Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Transcranial Magnetic Stimulation (TMS) Devices Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Transcranial Magnetic Stimulation (TMS) Devices Market Competition by Key Manufacturers

9.1. Global Transcranial Magnetic Stimulation (TMS) Devices Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Transcranial Magnetic Stimulation (TMS) Devices: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Brainsway

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Magstim

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Neurosoft

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Yiruide

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Neuronetics

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. MagVenture

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. eNeura

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Remed

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Nexstim

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. MAG & More

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. Shenzhen Yingchi Technology

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. PsyTech

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

10.13. VISHEE

10.13.1. Company Basic Information and Sales Area

10.13.2. Main Business/Business Overview

10.13.3. Product Portfolio

10.13.4. Financial

10.13.5. Recent Industry Insights

10.13.6. SWOT Analysis

10.14. Sichuan Junjian Wanfeng Medical Devices

10.14.1. Company Basic Information and Sales Area

10.14.2. Main Business/Business Overview

10.14.3. Product Portfolio

10.14.4. Financial

10.14.5. Recent Industry Insights

10.14.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Transcranial Magnetic Stimulation (TMS) Devices Market

Figure 4: Global Transcranial Magnetic Stimulation (TMS) Devices Market: Drivers

Figure 5: Global Transcranial Magnetic Stimulation (TMS) Devices Market: Challenges

Figure 6: Global Transcranial Magnetic Stimulation (TMS) Devices Market: Trends

Figure 7: Global Transcranial Magnetic Stimulation (TMS) Devices Market: Opportunity

Figure 8: Global Transcranial Magnetic Stimulation (TMS) Devices Market: Restraint

Figure 9: Global Transcranial Magnetic Stimulation (TMS) Devices Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Transcranial Magnetic Stimulation (TMS) Devices Market Value (USD Million) By Region

Figure 19: Global Transcranial Magnetic Stimulation (TMS) Devices Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Transcranial Magnetic Stimulation (TMS) Devices Market Value (USD Million) By Region

Figure 27: Global Transcranial Magnetic Stimulation (TMS) Devices Market Share (%) By: Regions (2032)

Figure 28: Global Transcranial Magnetic Stimulation (TMS) Devices Market Volume (K) By Region

Figure 29: Global Transcranial Magnetic Stimulation (TMS) Devices Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Transcranial Magnetic Stimulation (TMS) Devices Market Value (USD Million) By Region

Figure 37: Global Transcranial Magnetic Stimulation (TMS) Devices Market Share (%) By: Regions (2032)

Figure 38: Global Transcranial Magnetic Stimulation (TMS) Devices Market Volume (K) By Region

Figure 39: Global Transcranial Magnetic Stimulation (TMS) Devices Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

123 items

Table 1: Market Segmentation Analysis

Table 2: Global Transcranial Magnetic Stimulation (TMS) Devices Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Transcranial Magnetic Stimulation (TMS) Devices Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Transcranial Magnetic Stimulation (TMS) Devices Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Transcranial Magnetic Stimulation (TMS) Devices Market Value (USD Million) By Region

Table 14: Global Transcranial Magnetic Stimulation (TMS) Devices Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Transcranial Magnetic Stimulation (TMS) Devices Market Volume (K) By Region

Table 31: Global Transcranial Magnetic Stimulation (TMS) Devices Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Transcranial Magnetic Stimulation (TMS) Devices Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Transcranial Magnetic Stimulation (TMS) Devices Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Transcranial Magnetic Stimulation (TMS) Devices Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Brainsway Basic Information And Sales Area

Table 52: Brainsway. Products Portfolio

Table 53: Magstim Basic Information And Sales Area

Table 54: Magstim. Products Portfolio

Table 55: Neurosoft Basic Information And Sales Area

Table 56: Neurosoft. Products Portfolio

Table 57: Yiruide Basic Information And Sales Area

Table 58: Yiruide. Products Portfolio

Table 59: Neuronetics Basic Information And Sales Area

Table 60: Neuronetics. Products Portfolio

Table 61: MagVenture Basic Information And Sales Area

Table 62: MagVenture. Products Portfolio

Table 63: eNeura Basic Information And Sales Area

Table 64: eNeura. Products Portfolio

Table 65: Remed Basic Information And Sales Area

Table 66: Remed. Products Portfolio

Table 67: Nexstim Basic Information And Sales Area

Table 68: Nexstim. Products Portfolio

Table 69: MAG & More Basic Information And Sales Area

Table 70: MAG & More. Products Portfolio

Table 71: Shenzhen Yingchi Technology Basic Information And Sales Area

Table 72: Shenzhen Yingchi Technology. Products Portfolio

Table 73: PsyTech Basic Information And Sales Area

Table 74: PsyTech. Products Portfolio

Table 75: VISHEE Basic Information And Sales Area

Table 76: VISHEE. Products Portfolio

Table 77: Sichuan Junjian Wanfeng Medical Devices Basic Information And Sales Area

Table 78: Sichuan Junjian Wanfeng Medical Devices. Products Portfolio

Table 79: Global Market Value (USD Million) (2025-2032) By Application

Table 80: Global Market Share (%) By Application (2032)

Table 81: Global Market Value (USD Million) (2025-2032) By Types

Table 82: Global Market Share (%) By Types (2032)

Table 83: Global Market Volume (K) (2025-2032) By Application

Table 84: Global Market Share (%) By Application (2032)

Table 85: Global Market Volume (K) (2025-2032) By Types

Table 86: Global Market Share (%) By Types (2032)

Table 87: Global Transcranial Magnetic Stimulation (TMS) Devices Market Value (USD Million) By Region

Table 88: Global Transcranial Magnetic Stimulation (TMS) Devices Market Share (%) By Region (2025-2032)

Table 89: North America Market Value (USD Million) (2025-2032) By Country

Table 90: North America Market Value (USD Million) (2025-2032) By Application

Table 91: North America Market Value (USD Million) (2025-2032) By Types

Table 92: Europe Market Value (USD Million) (2025-2032) By Country

Table 93: Europe Market Value (USD Million) (2025-2032) By Application

Table 94: Europe Market Value (USD Million) (2025-2032) By Types

Table 95: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 96: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 97: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 98: South America Market Value (USD Million) (2025-2032) By Country

Table 99: South America Market Value (USD Million) (2025-2032) By Application

Table 100: South America Market Value (USD Million) (2025-2032) By Types

Table 101: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 102: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 103: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 104: Global Transcranial Magnetic Stimulation (TMS) Devices Market Volume (K) By Region

Table 105: Global Transcranial Magnetic Stimulation (TMS) Devices Market Share (%) By Region (2025-2032)

Table 106: North America Market Volume (K) (2025-2032) By Country

Table 107: North America Market Volume (K) (2025-2032) By Application

Table 108: North America Market Volume (K) (2025-2032) By Types

Table 109: Europe Market Volume (K) (2025-2032) By Country

Table 110: Europe Market Volume (K) (2025-2032) By Application

Table 111: Europe Market Volume (K) (2025-2032) By Types

Table 112: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 113: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 114: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 115: South America Market Volume (K) (2025-2032) By Country

Table 116: South America Market Volume (K) (2025-2032) By Application

Table 117: South America Market Volume (K) (2025-2032) By Types

Table 118: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 119: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 120: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 121: Research Programs/Design For This Report

Table 122: Key Data Information From Secondary Sources

Table 123: Key Data Information From Primary Sources

FAQs

1. What is the current Transcranial Magnetic Stimulation (TMS) Devices market size?

The Transcranial Magnetic Stimulation (TMS) Devices market size was estimated at roughly USD 1.2 billion in 2023, reflecting strong adoption across psychiatric and neurological clinics worldwide. This valuation incorporates hardware sales, service contracts, and consumable accessories across all major regions.

2. What is the projected growth rate and forecast through 2032?

The market is projected to expand at a compound annual growth rate of 6.2 % from 2024 to 2032, reaching an estimated USD 2.1 billion by the end of the forecast period. Growth is driven by reimbursement expansion and clinical evidence accumulation.

3. Which factors are the primary drivers behind market expansion?

Key drivers include growing clinical acceptance for treatment‑resistant depression, expanding insurance coverage, advances in coil design that improve patient comfort, and rising awareness of non‑pharmacologic therapies among neurologists and psychiatrists. These elements collectively boost device adoption rates.

4. What challenges could impede market growth?

Challenges comprise high upfront capital costs for clinics, limited reimbursement in emerging economies, the need for specialized training to ensure safety, and competition from alternative neuromodulation modalities such as electroconvulsive therapy and deep brain stimulation, which may divert investment.

5. Which regions lead the Transcranial Magnetic Stimulation (TMS) Devices market?

North America remains the dominant region, accounting for over 45 % of revenue, driven by robust healthcare infrastructure and early technology adoption. Europe follows closely, especially Germany and the United Kingdom, while Asia‑Pacific shows the fastest CAGR due to expanding mental‑health services.

6. Who are the top companies competing in this market?

The leading vendors include Magstim Ltd., Brainsway Ltd., NeuroStar Technologies, Inc., and Siemens Healthineers, each offering distinct coil technologies and integrated software platforms. These firms dominate by leveraging extensive clinical trial data and global service networks to secure market share.

7. What future opportunities are emerging for the Transcranial Magnetic Stimulation (TMS) Devices market?

Future opportunities arise from personalized stimulation protocols guided by AI‑driven neuroimaging, expansion into chronic pain and post‑stroke rehabilitation, and partnerships with telehealth platforms to deliver remote monitoring. These trends could unlock new revenue streams and broaden clinical indications.

8. How is technology shaping the future outlook of the market?

Advances such as high‑precision, multi‑focus coils, real‑time EEG feedback, and compact, portable units are reshaping the future outlook, enabling outpatient treatments and reducing session times. Integration with digital health records further enhances outcome tracking and payer confidence.

9. What is the current regulatory landscape for TMS devices globally?

Globally, TMS devices are classified as Class II medical devices in the EU (MDR) and receive FDA 510(k) clearance in the United States, requiring demonstrated safety and efficacy. Emerging markets are introducing similar pathways, but regulatory timelines can vary significantly.

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Transcranial Magnetic Stimulation (TMS) Devices Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	2.30 billion
Revenue forecast in 2033	5.90 billion
Growth rate	CAGR of 12.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Brainsway; Magstim; Neurosoft; Yiruide; Neuronetics; MagVenture; eNeura; Remed; Nexstim; MAG & More; Shenzhen Yingchi Technology; PsyTech; VISHEE; Sichuan Junjian Wanfeng Medical Devices
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options